Global Ulcerative Colitis Market 2017 to 2022 – Market Share, Growth, Statistics, Competitor Landscape, Key Players Analysis, Trends and Forecasts
Market Highlights
Global Ulcerative Colitis Market has been evaluated as growing market and expected that the market will reach high growth figures in the coming future. Ulcerative colitis is a type of inflammatory bowel disease( IBD) that usually affects the lower section of body such as sigmoid colon and the rectum. Belly pain or cramps, diarrhea and bleeding from the rectum are some of the common symptoms of the diseases. According to CDC, the worldwide incidence of ulcerative colitis is between 0.5 to 24.5 cases per 100,000 persons per year. The reappearance of the disease’ s symptoms is also high. According to Colitis Foundation of America, about 30 % of the people on remission are expected to suffer from the disease flare-up in the future following the treatment and remission.
Major factors leading to the growth of the market includes increasing prevalence of ulcerative colitis, higher preference for symptomatic therapeutic, better treatment of inflammatory bowel diseases, arrival of enhanced drugs and healthier investments in R & D programs. Increasing patient pool with unmet needs, new drugs entering the market, increasing global incidence & prevalence rate, and increasing investments towards research in small molecules are some of the other factors leading the market growth. Blockbuster drugs losing patent protection and growing the propensity for generic drugs are turning out to be restraints for the market. The lack of curative therapy and personalized therapy and medication are big opportunities for the market.
Access Report Details @ https:// www. marketresearchfuture. com / reports / ulcerative-colitis-market- 2354
Key Players:
Tel: + 1-646-845-9349 sales @ marketresearchfuture. com